DK37591D0 - Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse - Google Patents

Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse

Info

Publication number
DK37591D0
DK37591D0 DK91375A DK37591A DK37591D0 DK 37591 D0 DK37591 D0 DK 37591D0 DK 91375 A DK91375 A DK 91375A DK 37591 A DK37591 A DK 37591A DK 37591 D0 DK37591 D0 DK 37591D0
Authority
DK
Denmark
Prior art keywords
protein
preparing
procedure
expression vector
baculovirus expression
Prior art date
Application number
DK91375A
Other languages
English (en)
Other versions
DK37591A (da
Inventor
Richard W Compans
Ranjit Ray
Original Assignee
Molecular Eng Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Eng Ass filed Critical Molecular Eng Ass
Publication of DK37591A publication Critical patent/DK37591A/da
Publication of DK37591D0 publication Critical patent/DK37591D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK91375A 1988-09-02 1991-03-01 Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse DK37591D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24087788A 1988-09-02 1988-09-02
PCT/US1989/003740 WO1990002566A1 (en) 1988-09-02 1989-08-29 Fusion protein of paramyxovirus, method of production using recombinant baculovirus expression vector, vaccine comprising such protein and use thereof

Publications (2)

Publication Number Publication Date
DK37591A DK37591A (da) 1991-03-01
DK37591D0 true DK37591D0 (da) 1991-03-01

Family

ID=22908302

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91375A DK37591D0 (da) 1988-09-02 1991-03-01 Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse

Country Status (8)

Country Link
EP (1) EP0433371A4 (da)
JP (1) JPH04501058A (da)
AU (1) AU4314489A (da)
DK (1) DK37591D0 (da)
IL (1) IL91500A0 (da)
NZ (1) NZ230425A (da)
WO (1) WO1990002566A1 (da)
ZA (1) ZA896715B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611784B2 (en) * 1988-04-22 1991-06-20 Pharmacia & Upjohn Company Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
JP2649285B2 (ja) * 1990-11-29 1997-09-03 藤倉化成株式会社 ヒトパラインフルエンザ４ａ型ウイルスフュージョンプロテイン遺伝子及び該遺伝子を含む物質
EP0595970A4 (en) * 1991-07-17 1995-05-31 Commw Scient Ind Res Org IMPROVED VACCINE.
US5317097A (en) * 1991-10-07 1994-05-31 The Research Foundation Of State University Of New York Mutations in the gene encoding the α chain on platelet glycoprotein IB
US5298239A (en) * 1991-10-07 1994-03-29 The Research Foundation Of State University Of New York Mutations rendering platelet glycoprotein IB α less reactive
DE4407489A1 (de) * 1994-03-07 1995-09-14 Bayer Ag Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines
US5641751A (en) * 1995-05-01 1997-06-24 Centocor, Inc. Tumor necrosis factor inhibitors
US8778880B2 (en) 2004-02-02 2014-07-15 Ambrx, Inc. Human growth hormone modified at position 35
KR101699142B1 (ko) 2004-06-18 2017-01-23 암브룩스, 인코포레이티드 신규 항원-결합 폴리펩티드 및 이의 용도
US7638299B2 (en) 2004-07-21 2009-12-29 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
WO2006071840A2 (en) 2004-12-22 2006-07-06 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid
WO2006068802A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF
MX2007007590A (es) 2004-12-22 2007-12-10 Ambrx Inc Composiciones que contienen, metodos que involucran y usos de aminoacidos no naturales y polipeptidos.
EP2284191A3 (en) 2004-12-22 2011-07-20 Ambrx, Inc. Process for the preparation of hGH
US8080391B2 (en) 2004-12-22 2011-12-20 Ambrx, Inc. Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer
CA2609205A1 (en) 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
WO2007021297A1 (en) 2005-08-18 2007-02-22 Ambrx, Inc. COMPOSITIONS OF tRNA AND USES THEREOF
US20090018029A1 (en) 2005-11-16 2009-01-15 Ambrx, Inc. Methods and Compositions Comprising Non-Natural Amino Acids
DK2615108T3 (da) 2006-09-08 2017-01-30 Ambrx Inc Modificeret humant plasmapolypeptid eller fc scaffolds og deres anvendelser
DK2064333T3 (da) 2006-09-08 2014-05-05 Ambrx Inc Suppressor-trna-transkription i hvirveldyrceller
PT2061878E (pt) 2006-09-08 2014-04-22 Ambrx Inc Supressor híbrido arnt para células de vertebrados
PL2068909T3 (pl) 2007-03-30 2012-09-28 Ambrx Inc Modyfikowane polipeptydy fgf-21 i ich zastosowanie
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
US9938333B2 (en) 2008-02-08 2018-04-10 Ambrx, Inc. Modified leptin polypeptides and their uses
PL2318029T3 (pl) 2008-07-23 2018-03-30 Elanco Us Inc. Zmodyfikowane polipeptydy bydlęcego G-CSF i ich zastosowania
CA2738033C (en) 2008-09-26 2019-11-26 Ambrx, Inc. Non-natural amino acid replication-dependent microorganisms and vaccines
US8278418B2 (en) 2008-09-26 2012-10-02 Ambrx, Inc. Modified animal erythropoietin polypeptides and their uses
US20120283172A1 (en) 2009-12-21 2012-11-08 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
BR112012015461A2 (pt) 2009-12-21 2017-01-10 Ambrx Inc polipeptídeos de somatotropina boviina modificados e seus usos
EP3572091B1 (en) 2010-08-17 2023-12-13 Ambrx, Inc. Modified relaxin polypeptides and their uses
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
CN107108710B (zh) 2014-10-24 2022-02-15 百时美施贵宝公司 修饰的fgf-21多肽及其用途
PE20191716A1 (es) 2017-02-08 2019-12-05 Bristol Myers Squibb Co Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus
US4847081A (en) * 1984-07-18 1989-07-11 W. R. Grace & Co.-Conn. Synthetic bovine parainfluenza viral proteins
JPS6226300A (ja) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Ｈｔｌｖ−３ｄｎａのクロ−ニングおよび発現

Also Published As

Publication number Publication date
DK37591A (da) 1991-03-01
WO1990002566A1 (en) 1990-03-22
JPH04501058A (ja) 1992-02-27
ZA896715B (en) 1990-09-26
AU4314489A (en) 1990-04-02
EP0433371A1 (en) 1991-06-26
IL91500A0 (en) 1990-04-29
EP0433371A4 (en) 1991-10-30
NZ230425A (en) 1992-07-28

Similar Documents

Publication Publication Date Title
DK37591D0 (da) Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse
DK82784D0 (da) Fremgangsmade til fremstilling af lyofiliserede, adsorberede polyvalente vacciner
DK628488A (da) Stabilt mikroemulsion-rensemiddel og fremgangsmaade til fremstilling deraf samt dets anvendelse
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
DK316189A (da) Heteroaryloxy-n-isopropylanilider, fremgangsmaade til deres fremstilling samt deres anvendelse
ATA257190A (de) Virales polypeptid
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
DK540986D0 (da) 2-substitueret-(2-substitueret amino)-n-arylalkyl-3-(indol-3-yl)propanamider, fremgangsmaade til deres fremstilling samt deres anvendelse
DK20789A (da) Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme
DK19887D0 (da) Peptider med vasorelaxerende, natriuretisk og diuretisk virkning, fremgangsmaade til deres fremstiling, midler indeholdende forbindelserne og deres anvendelse
DK364288A (da) Vulkaniseret kautsjukemne, fremgangsmaade til fremstilling af dette samt etiket til brug ved fremgangsmaaden
DK196687D0 (da) Kombineret vaccine, samt fremgangsmaade til fremstilling deraf
CA2125486A1 (en) Platelet gpiiia p1 a1 and p1 a2 epitopes, their preparation and use
DK88989D0 (da) Substituerede pyrimidiner, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
DK469189D0 (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK178589A (da) Triazoloaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK46888A (da) 2-imino-1,3-dithietaner, fremgangsmaade til fremstilling af disse samt anvendelsen heraf som skadedyrsbekaempelsesmidler
DK231089D0 (da) Substituerede azolthioethere, fremgangsmaade til fremstilling deraf samt deres anvendelse som skadedyrsbekaempelsesmiddel
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
DK614589A (da) Imidazolholdige peptider samt fremgangsmaade til fremstilling deraf
FI894072A7 (fi) Rokotteena käytettävät polypeptidit
DK247884A (da) Substituerede tetrahydrothiopyran-3,5-dion-4-carboxamider, fremgangsmaade til deres fremstilling og deres anvendelse samt mellemprodukter til fremstillingen
DK440688D0 (da) Sulfonylaminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse
DK259089D0 (da) Aminoguanidinoaziner, fremgangsmaade til deres fremstilling samt deres anvendelse

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment